IGM Biosciences Inc
NASDAQ:IGMS
Cash Flow Statement
Cash Flow Statement
IGM Biosciences Inc
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(10)
|
(29)
|
(28)
|
(81)
|
(95)
|
(115)
|
(139)
|
(165)
|
(185)
|
(205)
|
(219)
|
(221)
|
(229)
|
(234)
|
(238)
|
(246)
|
(237)
|
(220)
|
(220)
|
(196)
|
(199)
|
(53)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
3
|
4
|
4
|
5
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
9
|
9
|
9
|
9
|
9
|
7
|
|
| Stock-Based Compensation |
1
|
3
|
5
|
8
|
13
|
16
|
20
|
26
|
32
|
38
|
42
|
45
|
44
|
47
|
48
|
47
|
43
|
38
|
42
|
38
|
36
|
30
|
|
| Other Non-Cash Items |
1
|
4
|
6
|
10
|
15
|
19
|
23
|
29
|
36
|
43
|
49
|
54
|
53
|
54
|
56
|
53
|
49
|
43
|
45
|
41
|
61
|
85
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
4
|
11
|
2
|
(1)
|
0
|
(0)
|
6
|
9
|
159
|
162
|
155
|
151
|
(9)
|
(8)
|
(7)
|
(5)
|
0
|
(1)
|
(7)
|
(14)
|
(195)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(21)
-163%
|
(11)
+46%
|
(68)
-491%
|
(80)
-17%
|
(93)
-17%
|
(113)
-21%
|
(125)
-11%
|
(136)
-8%
|
2
N/A
|
(3)
N/A
|
(6)
-78%
|
(18)
-207%
|
(182)
-914%
|
(182)
+0%
|
(192)
-5%
|
(184)
+4%
|
(168)
+8%
|
(166)
+1%
|
(153)
+8%
|
(144)
+6%
|
(156)
-9%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(4)
|
(9)
|
(18)
|
(22)
|
(23)
|
(18)
|
(13)
|
(10)
|
(9)
|
(9)
|
(10)
|
(11)
|
(13)
|
(14)
|
(12)
|
(11)
|
(8)
|
(6)
|
(6)
|
(3)
|
(2)
|
|
| Other Items |
30
|
30
|
106
|
76
|
91
|
115
|
53
|
29
|
(33)
|
(238)
|
(195)
|
(215)
|
(126)
|
54
|
78
|
81
|
18
|
46
|
38
|
70
|
102
|
120
|
|
| Cash from Investing Activities |
29
N/A
|
26
-10%
|
97
+267%
|
58
-40%
|
69
+19%
|
92
+33%
|
34
-63%
|
15
-55%
|
(43)
N/A
|
(247)
-472%
|
(205)
+17%
|
(226)
-10%
|
(137)
+39%
|
41
N/A
|
64
+57%
|
68
+6%
|
7
-89%
|
38
+427%
|
31
-17%
|
64
+104%
|
98
+54%
|
118
+20%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
(269)
|
216
|
216
|
216
|
218
|
3
|
3
|
221
|
220
|
218
|
218
|
69
|
114
|
114
|
114
|
45
|
1
|
2
|
1
|
1
|
|
| Net Issuance of Debt |
(10)
|
(10)
|
(15)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Cash from Financing Activities |
(10)
N/A
|
(10)
-2%
|
(285)
-2 687%
|
215
N/A
|
215
0%
|
215
+0%
|
217
+1%
|
2
-99%
|
3
+5%
|
221
+8 407%
|
220
0%
|
219
0%
|
219
+0%
|
71
-68%
|
115
+63%
|
115
0%
|
115
+0%
|
46
-60%
|
2
-95%
|
2
+1%
|
2
-6%
|
2
-27%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
11
N/A
|
(5)
N/A
|
(200)
-3 866%
|
205
N/A
|
204
0%
|
214
+5%
|
138
-35%
|
(107)
N/A
|
(176)
-65%
|
(24)
+86%
|
13
N/A
|
(12)
N/A
|
65
N/A
|
(71)
N/A
|
(3)
+96%
|
(9)
-235%
|
(61)
-581%
|
(84)
-38%
|
(132)
-57%
|
(87)
+35%
|
(43)
+50%
|
(36)
+15%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(9)
N/A
|
(25)
-173%
|
(21)
+17%
|
(85)
-316%
|
(102)
-19%
|
(116)
-14%
|
(131)
-14%
|
(138)
-5%
|
(146)
-5%
|
(7)
+95%
|
(13)
-86%
|
(16)
-28%
|
(29)
-82%
|
(196)
-571%
|
(196)
0%
|
(204)
-4%
|
(195)
+5%
|
(176)
+9%
|
(172)
+2%
|
(159)
+8%
|
(147)
+7%
|
(158)
-8%
|
|